CentriMag RVAS U.S. Post-approval Study Protocol
Trial status: Open for Enrollment
Why is this study being done?
The study objective is to gather post-market clinical data on the use of the CentriMag RVAS when used for temporary mechanical circulatory support of the right ventricle in patients with acute right ventricular failure from any cause
Who is eligible to participate?
- Right ventricular failure from any cause
- Primary coagulopathy or platelet disorders
- Allergy or sensitivity to heparin and all alternative anticoagulants